We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+27.1%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$168M
AUM Growth
+$5.88M
Cap. Flow
-$6.82M
Cap. Flow %
-4.05%
Top 10 Hldgs %
44.13%
Holding
98
New
36
Increased
11
Reduced
15
Closed
33

Top Buys

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$4.08M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.7M
3
MMSI icon
Merit Medical Systems
MMSI
+$2.6M
4
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
+$2.51M
5
HSTO
Histogen Inc. Common Stock
HSTO
+$2.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.6M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$3.44M
3
SPNC
Spectranetics Corp
SPNC
+$3.42M
4
MZOR
Mazor Robotics Ltd.
MZOR
+$3.42M
5
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$3.34M

Sector Composition

Rank Sector Weight
1 Healthcare 44.95%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
26
Edwards Lifesciences
EW
$49.4B
$2.23M 1.32%
+180,000
New +$2.08M
ISRG icon
27
Intuitive Surgical
ISRG
$122B
$2.19M 1.3%
+45,000
New +$2.12M
BRKR icon
28
Bruker
BRKR
$8.86B
$2.05M 1.22%
90,000
-25,000
-22% -$545K
BIIB icon
29
Biogen
BIIB
$30.4B
$1.98M 1.18%
6,471
-9,529
-60% -$3.02M
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.97M 1.17%
130,000
+30,000
+30% +$339K
ALGN icon
31
Align Technology
ALGN
$12.7B
$1.81M 1.08%
+35,000
New +$1.96M
DYAX
32
DELISTED
DYAX CORPORATION
DYAX
$1.8M 1.07%
200,000
-250,000
-56% -$2.27M
HSTO
33
DELISTED
Histogen Inc. Common Stock
HSTO
$1.79M 1.06%
+1,100
New +$2.3M
CHTP
34
CALL
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$1.66M 0.98%
+300,000
New +$1.51M
ATRC icon
35
AtriCure
ATRC
$1.77B
$1.6M 0.95%
+85,000
New +$1.74M
SGMO
36
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.57M 0.93%
86,606
-63,394
-42% -$1.22M
NSTG
37
DELISTED
NanoString Technologies, Inc.
NSTG
$1.55M 0.92%
+75,000
New +$1.43M
SPNC
38
DELISTED
Spectranetics Corp
SPNC
$1.52M 0.9%
50,000
-125,000
-71% -$3.42M
ILMN icon
39
Illumina
ILMN
$28.2B
$1.49M 0.88%
+10,280
New +$1.51M
GWPH
40
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.48M 0.88%
+25,000
New +$1.49M
ASRT
41
DELISTED
Assertio
ASRT
$1.45M 0.86%
1,667
+834
+100% +$636K
LCI
42
DELISTED
Lannett Company, Inc.
LCI
$1.43M 0.85%
10,000
-5,000
-33% -$776K
ENTA icon
43
Enanta Pharmaceuticals
ENTA
$400M
$1.4M 0.83%
+35,000
New +$1.27M
TXMD icon
44
TherapeuticsMD
TXMD
$23.8M
$1.26M 0.75%
+4,000
New +$1.27M
PBYI icon
45
Puma Biotechnology
PBYI
$434M
$1.18M 0.7%
11,330
-13,670
-55% -$1.61M
NUVA
46
DELISTED
NuVasive, Inc.
NUVA
$1.15M 0.68%
+30,000
New +$1.1M
EPZM
47
DELISTED
Epizyme, Inc
EPZM
$1.02M 0.61%
+45,000
New +$1.36M
KYTH
48
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$994K 0.59%
+25,000
New +$1.12M
ATRS
49
DELISTED
Antares Pharma, Inc.
ATRS
$875K 0.52%
+250,000
New +$1.11M
TEAR
50
DELISTED
TearLab Corporation
TEAR
$845K 0.5%
12,500
-5,000
-29% -$384K
1
2
3 4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Ghost Tree Capital held 98 positions worth $168M, up 3.6% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ghost Tree Capital withdrew a net $6.82M in Q1 2014, closing 33 positions and reducing 15 holdings. Its most notable exit was Gilead Sciences, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 50% a quarter earlier, followed by Technology.

Against the trend, Ghost Tree Capital opened a new position in AMAG Pharmaceuticals worth $3.72M.

  • Ghost Tree Capital's largest Q1 2014 buy was AMAG Pharmaceuticals: 192,057 shares worth $3.72M.
  • Ghost Tree Capital added most to CHELSEA THERAPEUTICS INT'L LTD in Q1 2014, an estimated $2.51M increase.
  • Ghost Tree Capital's biggest Q1 2014 reduction was Spectranetics Corp, cutting an estimated $3.42M.
  • Ghost Tree Capital fully exited Gilead Sciences in Q1 2014, selling an estimated $10.6M.
  • Ghost Tree Capital's ten largest holdings make up 44% of its $168M portfolio in Q1 2014.
  • Ghost Tree Capital opened 36 new positions and closed 33 in Q1 2014.
  • Ghost Tree Capital's portfolio value rose 3.6% quarter-over-quarter to $168M.

Based on Ghost Tree Capital's 13F filing for Q1 2014, filed 15 May 2014.